Histone Deacetylase Inhibitors Show a Potential Leishmanicidal Effect against Leishmania braziliensis in a Mouse Infection Model and Lead to Less Toxicity than Glucantime
Authors:
Open Access
- 6 May 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (19) , 19466-19479
Abstract
Leishmania braziliensis is the primary cause of cutaneous leishmaniasis (CL) in the New World. Current treatments have significant limitations, including severe side effects and parasite resistance. Histone deacetylases (HDAC) are critical regulators of chromatin structure and represent potential drug targets for leishmaniasis. This study evaluated three HDAC inhibitors (HDACi), TH60, TH74, and TH85, in BALB/c mice infected with L. braziliensis, comparing their efficacy to the standard treatment, glucantime. Two doses were tested, and lesion size, parasite load, kidney and liver enzyme levels, and histopathological analyses were carried out. HDACi effectively reduced lesion size and parasite presence, with lower toxicity and fewer organ alterations than glucantime. Among the tested compounds, TH60 was the best-tested HDACi. These findings highlight the potential application of the tested HDACi as leishmanicidal agents against L. braziliensis, positioning them as promising candidates for developing new drugs targeting cutaneous leishmaniasis.Keywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (306140/2021-7)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Seventh Framework Programme (602080)
This publication has 76 references indexed in Scilit:
- Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targetsMedcomm, 2023
- Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infectionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2022
- Global distribution of treatment resistance gene markers for leishmaniasisJournal of Clinical Laboratory Analysis, 2022
- A Review of Leishmaniasis: Current Knowledge and Future DirectionsCurrent Tropical Medicine Reports, 2021
- Mechanisms of Inflammatory Liver Injury and Drug-Induced HepatotoxicityCurrent Pharmacology Reports, 2018
- Lessons from other diseases: granulomatous inflammation in leishmaniasisSeminars in Immunopathology, 2015
- Classification and histological, immunohistochemical, and molecular diagnosis of inflammatory myocardial diseaseHeart Failure Reviews, 2012
- Dynamics of immune granuloma formation in a Leishmania braziliensis‐induced self‐limiting cutaneous infection in the primate Macaca mulattaThe Journal of Pathology, 2008
- Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspectsAdvanced Drug Delivery Reviews, 2008
- Anesthesia inhibits Poly I:C induced stimulation of natural killer cell cytotoxicity in miceClinical Immunology and Immunopathology, 1990